Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey

Abstract Introduction While various antiretrovirals have been studied as potential candidates for long‐acting pre‐exposure prophylaxis (PrEP), the bimonthly injectable cabotegravir—the first long‐acting form of PrEP—was approved in 2021. Event‐driven (ED) PrEP has been the most prevalent dosing regi...

Full description

Bibliographic Details
Main Authors: Jing‐Hao Hsu, Stephane Wen‐Wei Ku, Tsai‐Wei Chen, Chia‐Wen Li, Poyao Huang, Huei‐Jiuan Wu, Adam Bourne, Carol Strong
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Journal of the International AIDS Society
Subjects:
Online Access:https://doi.org/10.1002/jia2.26163